A recent discovery by scientists at OMRF could aid in the development of potential therapies for lymphedema.
Arthritis is the leading cause of disability in adults in the U.S. Understandably, this has led to much concern about the future of arthritis treatment.
An OMRF discovery could potentially open the door for the first drug option to treat age-related muscle weakness and atrophy.
Sathish Srinivasan was awarded $1.77 million to investigate valve development.
Scientists are developing at new ways to specifically target tumors.